Europe Microbiome Sequencing Services Market

Europe Microbiome Sequencing Services Market Size & Growth (2023 to 2028):

As per the research report, the size of the Europe Microbiome sequencing services market size is valued at USD 254.03 Million in 2023. It is expected to grow at a CAGR of 21.17% to reach USD 663.54 Million by 2028 during the forecast period 2023 to 2028.

The examination of microbial groups found in and on the human body is known as microbiome sequencing. The purpose of human microbiome research is to learn more about how bacteria function in health and disease. Previously, analyzing samples from human skin, stool, or blood required time-consuming and labor-intensive microbiological methods such as cultivating and isolating individual organisms, then phenotypic or genotypic analysis. However, the introduction of NGS has enabled a slew of high-profile joint studies to publish a wealth of data on the human microbiome, with NGS serving as an essential tool.

The growing use of microbiomes in genomics, proteomics, and metabolomics, and mechanical advancements in cutting-edge sequencing are driving the market growth. The market is being fueled by the growing scale of pharmaceutical enterprises and growing awareness of the benefits of microbiome sequencing for cancer treatment. 

The rise in chronic disease occurrences is having a substantial impact on market demand. In addition, the increasing biological research and development institutes, growing genomics studies, and rising regular disease incidences all contribute to the expansion of the microbiome sequencing services market.

Furthermore, rising healthcare spending in metropolitan areas and increased government support through investments drive demand for microbiome sequencing services. Also driving demand for the market is the growing importance of early diagnosis, as some diseases can be completely healed if caught early enough.

The government has strict laws and restrictions, and the cost of installing and maintaining the equipment is a little high. These factors are also predicted to limit the market for microbiome sequencing services. In addition, a market expansion might be hampered by a lack of innovation combined with extensive analysis. The market's growth rate is being slowed by fewer technicians, physicians, and scientists. The high cost of laboratory equipment is also hindering the growth of the microbiome sequencing services market. Factors such as the lack of proper rules and government directives are also impeding expansion.

This research report on the Europe Microbiome Sequencing Services Market has been segmented and sub-segmented into the following categories:

By Technology:

• sequencing by Synthesis (SBS)
• Sequencing by Ligation (SBL)
• Pyrosequencing
• Sanger Sequencing
• Others

By Application:

• shotgun Sequencing
• Targeted Gene Sequencing
• RNA Sequencing
• Whole Genome Sequencing
• Others

By Research Type:

• internal Research
• Outsourced Research

By Laboratory Type:

• Wet Lab
• Dry Lab

By End User:

• Pharmaceutical
• Biotechnology

By Country:

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

Geographically, the Europe held the second-largest share of the Microbiome sequencing services market. However, with the rise in genetic illnesses, the European region is likely to demonstrate promising growth during the forecast period. In addition, self-medication is becoming more popular, bringing the market's expansion. However, the increasing use of microbiomes in genomics, proteomics, and metabolomics are credited with the regional market growth. On the other hand, the countries such as the United Kingdom, Germany, Spain, Italy, and France are expanding the European microbiome sequencing services market.

The UK Microbiome Sequencing Services Market and Germany Microbiome Sequencing Services Market are witnessing a significant market share due to prominent companies, growing awareness of next-generation sequencing, and the availability of advanced healthcare infrastructure. In addition, the growing use of microbiomes in genomics, proteomics, and metabolomics, as well as advancements in technology in cutting-edge sequencing, are driving the European microbiome sequencing services market ahead.

KEY MARKET PLAYERS

Key players operating in the Europe Microbiome sequencing services market profiled in this report are Metabiomics Corp., Microbiome Therapeutics LLC, Microbiome Insights Inc., Rancho Biosciences, Zymo Research Corp., Molzym GmbH & Co., Ubiome Inc., Diversigen Inc., Merieux Nutrisciences Corporation, and Molecular Research LP.